BioPharm International, Emerging Therapies September 2022

Research into oncolytic viruses potentiated by stem cells shows promise for treating cancer.

Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.

Document integrity is critical in the provision of raw materials for cell and gene therapy manufacturing.

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.

For cell and gene therapies to reach their full potential, changes in manufacturing must be explored.

Looking back at the biologics and large molecule drugs approved by FDA in the past year can give us hints toward what will be approved in the future.

The growth of the biopharmaceuticals market is feeding back into economies and, in part, is driving the boom in life sciences and biotech ecosystems.